News
2025
-
Press Release
-
Sysmex Expands Portfolio and Accelerates Global Expansion through Acquisition of JEOL's Clinical Chemistry Testing Business
-
Information
-
Balancing Business Growth and Reducing Environmental Impact as the Industry’s First TNFD Adopter
-
Information
-
Sysmex Announces Participation in TICAD Business Expo & Conference Japan Fair
- Contributing to Global Health and Universal Health Coverage -
-
Press Release
-
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2026 (PDF：294KB)
-
Press Release
-
Announcement Regarding Revision of Financial Forecast for the Six Months Ending September 30, 2025 (PDF：190KB)
-
Information
-
Sysmex Corporation Selected as a Constituent of All ESG Indices Adopted by the GPIF
-
Information
-
Realizing Customer Safety and Environmental Friendliness -New Sysmex Solutions-
-
Press Release
-
Sysmex Becomes First in the Industry to Obtain Certification for Closed-loop Recycling of Reagent Containers under the Plastic Resource Circulation Act
-
Information
-
Sysmex Selected as One of the TIME’s World's Most Sustainable Companies of 2025
-
Information
-
Sysmex’s XR™-Series Automated Hematology Analyzer Receives U.S. FDA 510(k) Clearance
-
Press Release
-
Sysmex and Nissay Agree to Collaborate in Healthcare Field
- Creating New Initiatives Using Digital Solutions to Support Each Individual’s Healthcare Journey -
-
Press Release
-
Sysmex Expands and Relocates Production Base in Brazil
- Establishing a Robust Manufacturing Framework to Support Sustainable Growth in Central and South America -
-
Press Release
-
Sysmex Obtains Manufacturing and Marketing Approval for Japan's First Assay Kit Assessing the Risk of Adverse Reactions to Anti-Amyloid β Antibody Drugs for Alzheimer’s Disease
-
Press Release
-
Sysmex Establishes a Subsidiary in Greece
- Strengthening Sales and Customer Care Structures to Promote Business Expansion -
-
Group Company News
-
Demonstration of Remote Surgery Using the hinotori™ Surgical Robot System Successfully Performed Between Europe and Japan (Medicaroid)
-
Press Release
-
Sysmex and the United Graduate School of Child Development, the University of Osaka to Establish a Joint Research Department to Elucidate Pathology and Develop New Diagnostic Techniques for Neurodevelopmental and Neurodegenerative Diseases
-
Information
-
Sysmex’s Automated Blood Coagulation Analyzer CN™-6000 Receives U.S. FDA 510(k) Clearance
-
Press Release
-
Sysmex Completes Subsidiary's New Instrument Manufacturing Factory in Nagano, Japan, and Begins Product Shipments
- Strengthening the Group’s Instrument Production System to Ensure Stable Global Supply and Enhanced Productivity -
-
Press Release
-
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (PDF：357KB)
-
Press Release
-
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2025 (PDF：130KB)
-
Press Release
-
Notification Regarding Reversal of Deferred Tax Assets (Non-Consolidated Financial Results) (PDF：97KB)
-
Press Release
-
Announcement of Executive Changes (PDF：205KB)
-
Press Release
-
Announcement Regarding the Introduction of the Performance-Linked Stock Compensation Plan (PDF：216KB)
-
Press Release
-
Sysmex and Gaudi Clinical Agree on a Business Collaboration and Capital Alliance
- Aiming to Provide Safer, Higher Quality Treatments in the Field of Regenerative Cellular Medicine -
-
Press Release
-
Sysmex Group’s New Manufacturing Base in India Begins Full-Scale Operations and Launches “Make in India” Products
-
Press Release
-
Sysmex Establishes a Subsidiary in Kenya
- Strengthening Business Foundations in East Africa -
-
Press Release
-
Sysmex to Relocate Sysmex Group Headquarters to a New Location in Kobe City in Spring 2028
-
Press Release
-
Sysmex Acquires Naming Rights for the New Kobe Bunka Hall
- Contributing to Further Development of Culture and Arts in Kobe -
-
Information
-
[Conference presentation] Presenting the AD/PD™ 2025 International Conference on Alzheimer’s and Parkinson’s Diseases
-
Information
-
Sysmex to be Special Sponsor of Kobe Marathon 2025 – Supporting the Event with the Aims of Achieving a Healthy, Prosperous Society and Vibrant Local Communities –
-
Press Release
-
Sysmex and J-TEC Sign a Research Collaboration Agreement Regarding Sterility Testing in Regenerative Medicine and Cell Therapy
-
Press Release
-
Sysmex Begins Sales of Diabetes Testing Panel Including HISCL™ C-Peptide Assay Kit in Japan
-
Information
-
Implementing the Group-wide Unified Social Contribution Activity, the “Sysmex Gives Back Campaign”
-
Group Company News
-
Medicaroid Files for CE Mark Certification Under MDR for the hinotori™ Surgical Robot System
-
Information
-
Educational Initiatives for the Next Generation
- Implementing Health Education for Elementary School Students and SDG Education for Junior and Senior High School Students -
-
Press Release
-
Announcement of Organizational and Personnel Changes (PDF：212KB)
-
Information
-
Sysmex Receives ”Human Capital Management Excellence 2024 Gold Award” for Excellent Human Capital Management and Information Disclosure
-
Information
-
Sysmex Ranked in the Top 1% in the Sustainability Yearbook 2025 by S&P Global
-
Press Release
-
Notice Regarding the Completion of an Investigation by the Japan Fair Trade Commission (PDF：101KB)
-
Press Release
-
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2025 (PDF：317KB)
-
Press Release
-
Sysmex Announces First Case in Malaysia Performed with the hinotori™ Surgical Robot System
- Accelerating Market Introduction in the Asia-Pacific Region -
-
Information
-
Sysmex Selected as One of the Global 100's Most Sustainable Companies in the World for the Sixth Time
